- Home
- NSSC vs NVCR Comparison
NSSC vs NVCR Comparison
Compare NSSC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- NVCR
- Stock Information
- Founded
- NSSC 1969
- NVCR 2000
- Country
- NSSC United States
- NVCR Switzerland
- Employees
- NSSC N/A
- NVCR N/A
- Industry
- NSSC Telecommunications Equipment
- NVCR Medical/Dental Instruments
- Sector
- NSSC Telecommunications
- NVCR Health Care
- Exchange
- NSSC Nasdaq
- NVCR Nasdaq
- Market Cap
- NSSC 899.1M
- NVCR 1.9B
- IPO Year
- NSSC N/A
- NVCR 2015
- Fundamental
- Price
- NSSC $30.83
- NVCR $17.60
- Analyst Decision
- NSSC Strong Buy
- NVCR Buy
- Analyst Count
- NSSC 6
- NVCR 7
- Target Price
- NSSC $34.50
- NVCR $32.43
- AVG Volume (30 Days)
- NSSC 287.7K
- NVCR 1.4M
- Earning Date
- NSSC 08-25-2025
- NVCR 07-24-2025
- Dividend Yield
- NSSC 1.82%
- NVCR N/A
- EPS Growth
- NSSC N/A
- NVCR N/A
- EPS
- NSSC 1.22
- NVCR N/A
- Revenue
- NSSC $181,227,000.00
- NVCR $621,711,000.00
- Revenue This Year
- NSSC N/A
- NVCR $5.56
- Revenue Next Year
- NSSC $6.02
- NVCR $9.19
- P/E Ratio
- NSSC $25.24
- NVCR N/A
- Revenue Growth
- NSSC N/A
- NVCR 18.27
- 52 Week Low
- NSSC $19.00
- NVCR $14.17
- 52 Week High
- NSSC $58.09
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- NSSC 67.34
- NVCR 49.74
- Support Level
- NSSC $29.22
- NVCR $16.81
- Resistance Level
- NSSC $32.06
- NVCR $18.59
- Average True Range (ATR)
- NSSC 0.76
- NVCR 0.74
- MACD
- NSSC 0.12
- NVCR 0.08
- Stochastic Oscillator
- NSSC 82.80
- NVCR 56.18
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.